Home Stocks MacroGenics to sell manufacturing operations to Bora for $122.5M (MGNX:NASDAQ)
Stocks

MacroGenics to sell manufacturing operations to Bora for $122.5M (MGNX:NASDAQ)

by Deidre Salcido
written by Deidre Salcido 0 comments
Og Image 1200 29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png

  • MacroGenics (MGNX) said on Monday it agreed to sell its GMP drug substance manufacturing operations to Bora Pharmaceuticals Co., Ltd. for $122.5 million upfront.
  • The deal includes MacroGenics’ manufacturing facilities in Rockville and Frederick, Maryland, as well as its CDMO operations and related
Deidre Salcido

You may also like

CPI read: Airfares spike 21% in April from a year ago (JETS:NYSEARCA)

Iren’s stock pulls back as investors assess the steep price of the AI...

Intel’s stock extends its hot streak. This is the latest source of optimism.

Stock index futures fall as hopes of a U.S.-Iran resolution fade (SPX:)

U.S. stock futures fall, oil surges as Trump calls Iran’s latest offer to...

I’m giving $10,000 to my stepchildren. My wife warned me against gifts of...

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.

About Us

Welcome to AI Investor Picks, your trusted source for investment insights, financial strategies, and business opportunities. We are dedicated to providing cutting-edge information and analysis on a wide range of investment topics, including stocks, cryptocurrency, real estate, finance, and much more.

Facebook Twitter Youtube Linkedin Instagram

Pell Grant Eligibility Jumped 31% After FAFSA Simplification, GAO Finds

Recent Articles

6 Steps to Build Credit Before Buying a House
Bitcoin Price Reacts as U.S. Inflation Rises to Highest Level Since May 2023
CPI read: Airfares spike 21% in April from a year ago (JETS:NYSEARCA)

Featured

Pell Grant Eligibility Jumped 31% After FAFSA Simplification, GAO Finds
6 Steps to Build Credit Before Buying a House
Bitcoin Price Reacts as U.S. Inflation Rises to Highest Level Since May 2023

© 2025 AI Investor Picks – All Rights Reserved

AI Investor Picks
© 2025 AI Investor Picks - All Rights Reserved
Close